PERAMPANEL (FYCOMPA) FOR TREATMENT OF EPILEPSY (EXPERIENCE OF THE SVT. LUKA'S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)

QR Code

PERAMPANEL (FYCOMPA) FOR TREATMENT OF EPILEPSY (EXPERIENCE OF THE SVT. LUKA'S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)

Perampanel (Fycompa, Eisai LLC) is the most recent antiepileptic drug registered for application for additional therapy of patients of 12 y.o. and older with focal and secondary generalized seizures. Perampanel was licensed in the USA and European countries in 2012; it was registered in 2013 and ent...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. Yu. Mukhin, O. A. Pylaeva
Format:	Article
Language:	Russian
Published:	ABV-press 2015-04-01
Series:	Русский журнал детской неврологии
Subjects:	epilepsy focal seizures perampanel mechanism of action glutamate pharmacokinetics drug interactions dosage mode efficacy tolerability
Online Access:	https://rjdn.abvpress.ru/jour/article/view/35
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORT
by: K. Yu. Mukhin, et al.
Published: (2016-08-01)

Effectiveness and tolerability of perampanel in сhildren and adolescents (own experience of Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: K. Y. Mukhin, et al.
Published: (2022-01-01)

New possibilities of using perampanel in children. Efficacy and tolerability of perampanel in the treatment of epilepsy (literature review and experience of Svt. Luka’s Association of Medical Institutions)
by: K. Yu. Mukhin, et al.
Published: (2024-11-01)

COMPARATIVE EFFICАCY AND TOLERABILITY OF MONOTHERAPY WITH DEPAKINE CHRONOSPHERE, DRUGS OF CARBAMAZEPINE GROUP WITH EXTENDED RELEASE AND OXCARBAZEPINE IN SYMPTOMATIC AND CRYPTOGENIC FOCAL EPILEPSY (SVT. LUKA’S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)
by: K. Yu. Mukhin, et al.
Published: (2015-04-01)

USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
by: O. A. Pylaeva, et al.
Published: (2015-04-01)

Perampanel in the treatment of drug-resistant epilepsy in children
by: M. Yu. Bobylova, et al.
Published: (2018-01-01)

Efficacy and tolerability of Seizar (lamotrigine) in the treatment of epilepsy (experience of Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: O. A. Pylaeva, et al.
Published: (2020-09-01)

Efficacy and tolerability of rufinamide in the treatment of epilepsy (experience of the Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: K. Yu. Mukhin, et al.
Published: (2018-11-01)

Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures
by: Besag F, et al.
Published: (2016-05-01)

SAFETY AND TOLERABILITY OF ANTIEPILEPTIC DRUGS AT WOMEN WITH EPILEPSY (DATA OF SVT. LUKA’S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)
by: K. Yu. Мukhin, et al.
Published: (2015-04-01)

EFFICACY AND TOLERABILITY OF LACOSAMIDE (VIMPAT) FOR TREATMENT OF EPILEPSY IN ADULTS (A REVIEW)
by: O. A. Pylaeva, et al.
Published: (2015-04-01)

PERAMPANEL IN THE TREATMENT OF REFRACTORY EPILEPSY IN EVERYDAY CLINICAL PRACTICE IN ADOLESCENTS
by: S. G. Burd, et al.
Published: (2017-03-01)

ZONISAMIDE (ZONEGRAN) IN THE TREATMENT OF EPILEPSY IN ADULTS AND CHILDREN (A REVIEW AND CLINICAL CASE)
by: K. Yu. Мukhin, et al.
Published: (2015-04-01)

OUTCOME AND TRANSFORMATION OF FEBRILE SEIZURES IN CHILDREN (DATA OF SVT. LUKA'S INSTITUTE OF CHILD NEUROLOGY & EPILEPSY)
by: M. B. Mironov, et al.
Published: (2015-10-01)

EFFICACY AND TOLERABILITY OF LEVETIRACETAM (KEPPRA®) IN THE TREATMENT OF EPILEPSY: REVIEW OF LITERATURE
by: K. Yu. Mukhin, et al.
Published: (2015-06-01)

Efficacy and tolerability of brivaracetam in the treatment of epilepsy: literature review and own experience
by: O. A. Pylaeva, et al.
Published: (2018-11-01)

Efficiency of vagus nerve stimulation in epilepsy (literature review and case report)
by: O. A. Pylaeva, et al.
Published: (2019-07-01)

Perampanel in the additional therapy of focal and primary generalized tonic-clonic seizures in children 4–12 years old: clinical data, experience of use and practical recommendations
by: K. Yu. Mukhin, et al.
Published: (2021-07-01)

USE OF ZONISAMIDE (ZONEGRAN) IN THE TREATMENT OF EPILEPSY: EMPHASIS ON MONOTHERAPY OF FOCAL SEIZURES (A REVIEW OF FOREIGN LITERATURE)
by: O. A. Pylaeva, et al.
Published: (2015-04-01)

CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS OF IDIOPATHIC CHILDHOOD FOCAL EPILEPSY WITH CENTROTEMPORAL SPIKES
by: K. Yu. Mukhin
Published: (2015-11-01)

BUDGET IMPACT ANALYSIS OF PERAMPANEL FOR ADJUNCTIVE TREATMENT IN EPILEPSY PATIENTS 12 YEARS OF AGE AND OLDER FOR PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN THE RUSSIAN FEDERATION
by: V. R. Mkrtchyan, et al.
Published: (2016-09-01)

IDIOPATHIC FOCAL EPILEPSY WITH PSEUDOGENERALIZED SEIZURES (A CLINICAL CASE)
by: I. A. Sadekov, et al.
Published: (2015-04-01)

Perampanel in adjunctive therapy of patients with brain tumor-related epilepsy: real-world data
by: G. G. Samsonova, et al.
Published: (2023-01-01)

Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data
by: Yani Hu, et al.
Published: (2025-06-01)

EFFICACY AND TOLERABILITY OF PERAMPANEL AS ADDITIONAL DRUG OF TEENAGERS WITH DRUG-RESISTANT PARTIAL EPILEPSY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY CONDUCTED IN THE RUSSIAN FEDERATION
by: E. D. Belousova
Published: (2016-05-01)

VALPARIN XR IN THE TREATMENT OF EPILEPSY (А REVIEW OF LITERATURE AND A DESCRIPTION OF CLINICAL CASES)
by: N. V. Freidkova, et al.
Published: (2015-11-01)

Classification and definition of epilepsy. Position paper by the International League Against Epilepsy on Nosology and Definitions of Epilepsy Syndromes dated 2021
by: K. Yu. Mukhin, et al.
Published: (2022-06-01)

Lamotrigine (Sazar) in the treatment of epilepsy: four years of experience in Svt. Luka's Association of Medical institutions for the Diagnosis, Treatment, and Rehabilitation of Nervous System Diseases and Epilepsy
by: K. Yu. Mukhin, et al.
Published: (2022-12-01)

PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM
by: N. K. Mazina, et al.
Published: (2017-05-01)

ILAE CLASSIFICATION OF THE EPILEPSIES: THE 2017 REVISION AND UPDATE
by: G. N. Avakyan, et al.
Published: (2017-05-01)

NEW OPPORTUNITIES PHARMACOTHERAPY PATIENTS WITH REFRACTORY EPILEPSY
by: P. N. Vlasov
Published: (2017-03-01)

The first combined Russian experience of using perampanel in children and adolescents with epilepsy in everyday clinical practice
by: O. A. Rakhmanina, et al.
Published: (2022-09-01)

Experience of using EpiTapp application in structural focal epilepsy
by: E. A. Narodova, et al.
Published: (2022-01-01)

Results of the expert forum on the use of perampanel in adolescents with epilepsy in everyday clinical practice
by: article Editorial
Published: (2021-02-01)

FOCAL MOTOR SEIZURES WITH TYPICAL AUTOMATISMS (FOCAL AUTOMOTOR SEIZURES)
by: M. B. Mironov, et al.
Published: (2015-04-01)

Definition and classification of epilepsy. Classification of epileptic seizures 2016
by: K. Yu. Mukhin
Published: (2017-04-01)

IMPACT OF ANTIEPILEPTIC DRUGS ON COGNITIVE FUNCTIONS: FOCUS ON PERAMPANEL
by: E. D. Belousova
Published: (2016-12-01)

Febrile infection-related epilepsy syndrome: long-term consequences (own observations)
by: A. V. Drobitova, et al.
Published: (2020-05-01)

Juvenile Myoclonic Epilepsy. Update
by: I. V. Volkov, et al.
Published: (2020-07-01)

Third generation antiepileptic drugs: mechanism of action, pharmacokinetics, interaction and use in childhood
by: Z. G. Tadtaeva, et al.
Published: (2023-07-01)